Cancers (Sep 2022)

Clone Phylogenetics Reveals Metastatic Tumor Migrations, Maps, and Models

  • Antonia Chroni,
  • Sayaka Miura,
  • Lauren Hamilton,
  • Tracy Vu,
  • Stephen G. Gaffney,
  • Vivian Aly,
  • Sajjad Karim,
  • Maxwell Sanderford,
  • Jeffrey P. Townsend,
  • Sudhir Kumar

DOI
https://doi.org/10.3390/cancers14174326
Journal volume & issue
Vol. 14, no. 17
p. 4326

Abstract

Read online

Dispersal routes of metastatic cells are not medically detected or even visible. A molecular evolutionary analysis of tumor variation provides a way to retrospectively infer metastatic migration histories and answer questions such as whether the majority of metastases are seeded from clones within primary tumors or seeded from clones within pre-existing metastases, as well as whether the evolution of metastases is generally consistent with any proposed models. We seek answers to these fundamental questions through a systematic patient-centric retrospective analysis that maps the dynamic evolutionary history of tumor cell migrations in many cancers. We analyzed tumor genetic heterogeneity in 51 cancer patients and found that most metastatic migration histories were best described by a hybrid of models of metastatic tumor evolution. Synthesizing across metastatic migration histories, we found new tumor seedings arising from clones of pre-existing metastases as often as they arose from clones from primary tumors. There were also many clone exchanges between the source and recipient tumors. Therefore, a molecular phylogenetic analysis of tumor variation provides a retrospective glimpse into general patterns of metastatic migration histories in cancer patients.

Keywords